Risk of iron overload in obesity and implications in metabolic health
-
A. Moore Heslin; A. O’donnell; M. Buffini; A. P. Nugent; J. Walton; A. Flynn; B. A. McNulty
Risk of iron overload in obesity and implications in metabolic health Nutrients
Publication Category: Metabolic Health
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies
-
M. A. McArdle; O. M. Finucane; R. M. Connaughton; A. M. McMorrow; H. M. Roche
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies Front Endocrinol (Lausanne)
Emerging therapeutic potential for peptide YY for obesity-diabetes
- R. A. Lafferty; P. R. Flatt; N. Irwin Emerging therapeutic potential for peptide YY for obesity-diabetes Peptides
Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes
- R. A. Lafferty; P. R. Flatt; N. Irwin Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes Curr Opin Endocrinol Diabetes Obes
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation
-
A. M. Lynch; N. Pathak; V. Pathak; F. P. M. O’Harte; P. R. Flatt; N. Irwin; V. A. Gault
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation Diabetologia
Complications of obesity
-
D. Kinlen; D. Cody; D. O'Shea
Complications of obesity Qjm
Obesity and carotid artery remodeling
-
M. Kozakova; C. Palombo; C. Morizzo; K. Højlund; M. Hatunic; B. Balkau; P. M. Nilsson; E. Ferrannini
Obesity and carotid artery remodeling Nutr Diabetes
Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level
-
K. Kearns; A. Dee; A. P. Fitzgerald; E. Doherty; I. J. Perry
Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level BMC Public Health
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
- N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol
Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes
- N. Irwin; I. A. Montgomery; F. P. O'Harte; P. Frizelle; P. R. Flatt Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes Int J Obes (Lond)